Skip to main content
SpringerLink
Log in

Medikamentöse Rezidivprophylaxe

  • Chapter
Book cover Interventionelle Gefäßtherapie

  • 53 Accesses

Zusammenfassung

Die Entwicklung von Restenosen stellt ein wichtiges Problem nach Koronardilatationen (PTCA) dar. Dies gilt auch für stentversorgte Koronarstenosen. Trotz zahlreicher untersuchter Substanzen und experimentell vielversprechender Daten ist derzeit kein allgemein anerkanntes medikamentöses Therapieprinzip verfügbar. Ursächlich verantwortlich dafür sind vermutlich die Komplexen der Restenose zugrundeliegenden Prozesse in der Gefäßwand.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 59.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Appleman YEA, Piek JJ, Srikwerda S, Tijssen JGP, de Feyter PJ, David GK, Serruys PW, Margolis JR, Koelemay MJ, Montauban van Swijndregt EWJ, Koolen JJ (1996) Randomised trial of excimer laser angioplasty for treatment of obstructive coronary artery disease. Lancet 347:79–84

    Article  Google Scholar 

  2. Bairati I, Roy L, Meyer F (1992) Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85:950–956

    Article  PubMed  CAS  Google Scholar 

  3. Beigel Y, Zafrir N, Teplitzky Y, Neumann et al (1995) The effect of lovastatin on early restenosis. J Clin Pharmacol 35:599–605

    Article  PubMed  CAS  Google Scholar 

  4. The EPILOG investigators (1997) Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 366:1689–1696

    Google Scholar 

  5. Ellis SG, Roubin GS, Wilentz J, Douglas JS et al (1989) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117:777–782

    Article  PubMed  CAS  Google Scholar 

  6. Emanuelsson H, Beatt JK, Bagger JP, Balcon R et al (1995) Longterm effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation 91: 1689–1696

    Article  PubMed  CAS  Google Scholar 

  7. The EPIC investigators (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343:881–886

    Article  Google Scholar 

  8. EPIC investigators (1994) Use of a monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956–961

    Article  Google Scholar 

  9. Eriksen UH, Amtorp O, Bagger JP, Emauelsson H et al (1995) A randomized Scandinavian trial of angiopeptin versus placebo for the prevention of restenosis after coronary balloon angioplasty. Am Heart J 130:1–8

    Article  PubMed  CAS  Google Scholar 

  10. Gestrichen

    Google Scholar 

  11. Faxon D, Spiro T, Minor S, Douglas J et al (1994) Low molecular weight heparin in prevention of restenosis after angioplasty: results of enoxaparin restenosis (ERA) trial. Circulation 90:908–914

    Article  PubMed  CAS  Google Scholar 

  12. Fischman DL, Leon MB, Baim DS for the Stress Investigators (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501

    Article  PubMed  CAS  Google Scholar 

  13. Frishman WH, Chiu R, Landzberg BR, Weiss M (1998) Medical therapies for the prevention of restenosis after percutaneous coronary interventions. Curr Probl Cardiol 23:534–635

    PubMed  CAS  Google Scholar 

  14. Gibson CM, Goel M, Cohe DJ, Piana RN et al (1998) Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the restore trial. J Am Coll Cardiol 32:28–34

    Article  PubMed  CAS  Google Scholar 

  15. Grigg LE, Kay TW, Valentine PA, Larkins R et al (1989) Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 13:665–672

    Article  PubMed  CAS  Google Scholar 

  16. Guzmann LA, Mick MJ, Arnold AM, Forudi F, Whitlow PL (1996) Role of the intimal hyperplasia and arterial remodeling after balloon angioplasty, an experimental study in the atherosclerotic rabbit model. Arterioscler Thromb Vasc Biol 16:479–487

    Article  Google Scholar 

  17. Hehrlein C, Zimmermann M, Pill J, Metz J, Kübler W, von Hodenberg E (1994) The role of elastic recoil after balloon angioplasty of rabbit arteries and ist prevention by stent implantation. Eur Heart J 15:277–280

    Article  PubMed  CAS  Google Scholar 

  18. Hehrlein C, Gollan C, Dönges K, Metz J, Riessen R, Fehsenfeld P, von Hodenberg E, Kübler W (1995) Low-dose Radioactive endovascular and neointimal hyperplasia in rabbits. Circulation 92:1570–1575

    Article  PubMed  CAS  Google Scholar 

  19. Hoberg E, Dietz R, Frees U, Katus A et al (1994) Low-dose Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J 71:254–260

    Article  PubMed  CAS  Google Scholar 

  20. Holmes DR, Topol EJ, Califf RM, Berdan LG, Leya F, Berger PB, Whitlow PB, et al. (1995) A multicenter randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 91: 1966–1974

    Article  PubMed  Google Scholar 

  21. Hoorigan MCE, Teheng JE, Calif RM et al (1996) maximal benefit of integrilin platelet IIb/ííía blockade 6–12 hours after therapy: Result of the IMPACT-II trial. J Am Coll Cardiol 27:55A

    Article  Google Scholar 

  22. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP (1996) Differences in compensatory vessel enlargement, not intimai formation, account for restenosis after angioplasty in the hypercholsterolemic rabbit model. Circulation 89:2809–2815

    Article  Google Scholar 

  23. Keefe JH, McCallister BD, Bateman TM, Kuhnlein DL et al (1992) Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 19:1597–1600

    Article  Google Scholar 

  24. Knudston ML, Flintoft VF, Roth DL, Hansen JL et al (1990) Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 15: 691–697

    Article  Google Scholar 

  25. Konus WC, Kirchhofer D, Hadvary P, et al. (1992) Reversible conformational changes induced in glycoprotein IIb-ííía by a potent and selective peptidomimetic inhibitor. Blood 80:2539–2547

    Google Scholar 

  26. Leon MB, Moses JW, Lansky AJ, Chiu Wong S, Navaz DW, Whitlow PI, Fish DR, Kluck B, Gorgianni J, Kuntz RE, Teirstein PS (1999) Intracoronary gamma radiation for the prevention of recurrent instent restenosis: final results from the Gamma 1 trial. Ciruclation 100, 18 I-75:384

    Google Scholar 

  27. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holms DR, Kerieakes D, Kuntz RE (2001) Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344:250–256

    Article  PubMed  CAS  Google Scholar 

  28. Luo H, Toshihiko N, Eigler NL, Forrester JS et al (1996) Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary vasoconstriction. Arterioscler Thromb Vasc Biol 16:1393–1398

    Article  CAS  Google Scholar 

  29. MARCATOR study group (1995) Effect of high-dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind placebo-controlled trial of calizapril. J Am Coll Cardiol 2:362–369

    Google Scholar 

  30. Maresta A, Balducelli M, Cantini L, Casari A et al (1994) Trapidil (Triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Circulation 90:2710–2715

    Article  PubMed  CAS  Google Scholar 

  31. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Kent KM, Stone GW, Leon MB (1999) Angiographic patterns of in-stent restenosis: classification an implication for long-term outcome. Circulation 100:1872–1878

    Article  PubMed  CAS  Google Scholar 

  32. MERCATOR study group (1992) Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter randomized, double blind placebo-controlled trial. Circulation 86:100–110

    Article  Google Scholar 

  33. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong SC, Hong MK, Kovach JA, Leon MB (1996) Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 94:35–43

    Article  PubMed  CAS  Google Scholar 

  34. O’Keefe JH, Giorgi LV, Hartzler GO, Good T et al (1991) Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 67:373–376

    Article  PubMed  Google Scholar 

  35. Patcheke H, Ruf A (1997) Thrombolyse and Antikoagulation in der Kardiologie. Fibrinolysis 11: 23–28

    Google Scholar 

  36. Pepine CJ, Hirshfeld JW, MacDonald RG, Henderson MA et al (1990) A controlled trial of cortico-steroids to prevent restenosis after coronary angioplasty. Circulation 81:1753–1761

    Article  PubMed  CAS  Google Scholar 

  37. Raizner AE, Hollman J, Abukhalil J, Demke D, for the Ciprostene Invstigators (1993) Ciprostene for restenosis revisted: quantitative analysis of angiograms. J Am Coll Caridol 21:321A

    Google Scholar 

  38. Reifart N, Vandormael M, Krajcar M, Göhring S, Preussler W, Schwarz F, Störger H, Hofmann M, Klepper J, Müller S, Haase J (1997) Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer laser, rotational atherectomy and balloon angioplasty comparison. ERBAC study. Circulation 96:91–98

    Article  PubMed  CAS  Google Scholar 

  39. Reis GS, Sipperly ME, McCabe CH, Sacks FM et al (1989) Randomised trail of fish oil for prevention of restenosis after coronary angioplasty. Lancet 2: 177–181

    Article  PubMed  CAS  Google Scholar 

  40. Roth A, Eshchar Y, Keren G, Kerbel S et al (1994) Effect of magnesium on restenosis after percutaneous transluminal coronary angioplasty: a clinical and and angiographic evaluation in a randomized patient population: a pilot study: the Ichilov magnesium study group. Eur Heart J 15:1164–1173

    PubMed  CAS  Google Scholar 

  41. Sapirstein W, Zuckerman B, Dillard J (2001) Editorial: FDA approval of coronary-artery brachytherapy. N Engl J Med 344:297–299

    Article  PubMed  CAS  Google Scholar 

  42. Savage MP, Goldberg S, MacDonald RG, Bass TA et al (1991) Multi Hospital Eastern Atlantic Restenosis Trial II: a placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty. Am Heart J 122: 1239–1243

    Article  PubMed  CAS  Google Scholar 

  43. Schömig A, Neumann FJ, Kastrati A, Schühlen H et al (1996) Randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334:1084–1089

    Article  PubMed  Google Scholar 

  44. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE et al (1988) Aspirin an dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318:1714–1719

    Article  PubMed  CAS  Google Scholar 

  45. Schweizer J, Kirch W (1999) Restenoseprophylaxe nach Gefäßinterventionen - Ansatzpunkte in der medikamentösen Behandlung. Arzneimitteltherapie 17:151–155

    Google Scholar 

  46. Schweizer J, Kirch W, Koch R, Hellner G, Uhlman K (1998) Effect of high dose verpapamil on restenosis after peripheral angioplasty. J Am Coll Cardiol 31:1299–1305

    Article  PubMed  CAS  Google Scholar 

  47. Serruys PW, Rutsch W, Heyndricks GR, Danchin N et al (1991) Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. Circulation 84: 1568–1580

    Article  PubMed  CAS  Google Scholar 

  48. Serruys PW, Klein W, Tijssen JPG et al (1993) Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: a multicenter randomized double-blind placebo-controlled trial. Circulation 88:1588–1601

    Article  PubMed  CAS  Google Scholar 

  49. Serruys PW, de Jaegere P, Kiemeneij F et al (1994) A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489–495

    Article  PubMed  CAS  Google Scholar 

  50. Sheppard R, Eisenberg MJ (2001) Editorial: Intracoronary radiotherapy for restenosis. N Engl J Med 344:295–296

    Article  PubMed  CAS  Google Scholar 

  51. Teirstein PS, Massullo V, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P (1997) Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336:1697–1703

    Article  PubMed  CAS  Google Scholar 

  52. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P (2000) Three-year clinical and angiographic follow-up after intracoronary radiation. Circulation 101:360–365

    Article  PubMed  CAS  Google Scholar 

  53. Topol EJ, Leya F, Pinkerton CA et al (1993) A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 329:221–227

    Article  PubMed  CAS  Google Scholar 

  54. Van Belle E, Maillard L, Tio FO, Isner JM (1997) Accelerated endothelialization by local delivery of recombinant vascular endothelial growth factor reduces in-stent intima formation. Biocehm Biophys Res Commun 235:311–316

    Article  Google Scholar 

  55. Van der Loo B, Martin JF (1997) The adventitia, endothelium and atherosclerosis. Int J Microcirc 17: 280–288

    Article  Google Scholar 

  56. Verin V, Popowki Y, De Bruyne B, Baumgart D, Sauerwein W, Lins M, Kovacs G, Thomas M, Calman F, Disco C, Serruys PW, Wijns W fot the Dose-Finding Study Group (2001) Endoluminal beta radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med 344: 243–249

    CAS  Google Scholar 

  57. von Hodenberg E, Tost B, Sheffold T (2000) Neue Strategien zur Behandlung der Restenose. Z Kardiol 89(Suppl 7):VII/19-VII/22

    Google Scholar 

  58. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinske AS et al (1994) Lack of effect of lovastatin on restenosis after coronary angioplasty: Lovastatin restenosis trial study group. N Engl J Med 331:1331–1337

    Article  PubMed  CAS  Google Scholar 

  59. White CW, Knudtson M, Schmidt D, Chisholm RJ et al (1987) Neither ticlopidine nor aspirin-dipyridamole prevents restenosis post PTCA: results from a randomized placebo-controlled multicenter trial (abstract). Circulation 76:IV-213

    Article  Google Scholar 

  60. Whitworth HB, Roubin GS, Hollmann J, Meier B et al (1986) Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 8:1271–1276

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. W. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kardiologische Fachklinik Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Heinz-Meise-Str. 100, Rotenburg a.d.F., 36199, Germany

    Christian Vallbracht

  2. LVA Aggertalklinik, Am Sondersiefen 18, Engelskirchen, 51766, Germany

    Franz-Josef Roth

  3. Abteilung für Angiologie, Dominikus-Krankenhaus Düsseldorf, Am Heerdter Krankenhaus 2, Düsseldorf, 40549, Germany

    Andreas L. Strauss (Chefarzt) (Chefarzt)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schneider, W. (2002). Medikamentöse Rezidivprophylaxe. In: Vallbracht, C., Roth, FJ., Strauss, A.L. (eds) Interventionelle Gefäßtherapie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57540-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57540-2_33

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63296-9

  • Online ISBN: 978-3-642-57540-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation